Krishna Peri
Director/Board Member at H&P Labs, Inc.
Profile
Krishna Peri is the founder of Pharma-G, Inc. He is currently working as a Director at H&P Labs, Inc. Previously, he worked as a Vice President-Research at Theratechnologies, Inc. He holds a doctorate degree from the University of Saskatchewan.
Krishna Peri active positions
| Companies | Position | Start |
|---|---|---|
H&P Labs, Inc.
 H&P Labs, Inc. Miscellaneous Commercial ServicesCommercial Services H&P Labs, Inc. operates as a biotechnology firm. It develops drugs to fight infectious viral diseases for public health and biodefense missions. The company was founded by John Michel T. Huss on June 7, 2013 and is headquartered in Westmount, Canada. | Director/Board Member | - |
Former positions of Krishna Peri
| Companies | Position | End |
|---|---|---|
Pharma-G, Inc.
 Pharma-G, Inc. Pharmaceuticals: MajorHealth Technology Part of Theratechnologies, Inc., Pharma-G, Inc. is a Canadian company that develops proteomics pharmaceuticals. The company is located in Canada. The company was founded by Krishna Peri. Pharma-G was acquired by Theratechnologies, Inc. on October 04, 2000 for $5.03 million. | Founder | - |
| THERATECHNOLOGIES INC. | Chief Tech/Sci/R&D Officer | - |
Training of Krishna Peri
| University of Saskatchewan | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| THERATECHNOLOGIES INC. | Health Technology |
| Private companies | 2 |
|---|---|
Pharma-G, Inc.
Pharma-G, Inc. Pharmaceuticals: MajorHealth Technology Part of Theratechnologies, Inc., Pharma-G, Inc. is a Canadian company that develops proteomics pharmaceuticals. The company is located in Canada. The company was founded by Krishna Peri. Pharma-G was acquired by Theratechnologies, Inc. on October 04, 2000 for $5.03 million. | Health Technology |
H&P Labs, Inc.
H&P Labs, Inc. Miscellaneous Commercial ServicesCommercial Services H&P Labs, Inc. operates as a biotechnology firm. It develops drugs to fight infectious viral diseases for public health and biodefense missions. The company was founded by John Michel T. Huss on June 7, 2013 and is headquartered in Westmount, Canada. | Commercial Services |
- Stock Market
- Insiders
- Krishna Peri
